Patents by Inventor Ellen Rosalie A. VAN GULCK

Ellen Rosalie A. VAN GULCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND SMALL MOLECULE PDL1 OR PD1 INHIBITOR
    Publication number: 20220305114
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and a small molecule PDL1 or PD1 inhibitor are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described. Kits comprising the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 29, 2022
    Inventors: Helen HORTON, Ellen Rosalie A. VAN GULCK, David Craig MC GOWAN
  • COBMINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY
    Publication number: 20220296703
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an anti-PD-1 or anti-PD-L1 antibody or antigen-binding fragment thereof are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 22, 2022
    Inventors: Helen HORTON, An Martine M. DE CREUS, Ellen Rosalie A. VAN GULCK
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 ANTIBODY
    Publication number: 20220233685
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an anti-PD-1 antibody or antigen-binding fragment thereof are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Inventors: Helen HORTON, An Martine M. DE CREUS, Ellen Rosalie A. VAN GULCK
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND PD-L1 INHIBITORS
    Publication number: 20220233684
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and PD-L1 inhibitors are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations of HBV vaccines and PD-L1 inhibitors are also described. Kits comprising the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Inventors: Helent HORTON, Sven Franciscus Anna VAN BRANDT, Ellen Rosalie A. VAN GULCK, Maria Johanna Petronella VAN DONGEN, David Craig MC GOWAN